Considering the mostly cancer-promoting effect of tumor-associated macrophages (TAMs), which have a “tumor-friendly”, M2-like phenotype, inhibitors of PARP-14 may have the potential to reverse M2 polarization of TAM, similar to models of IL-4-induced M2 polarization. Here, IL4 is linked to neoplasm.